Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Besse

Showing results (291-300 of 512) with videos related to

Pageof 52
Sort By:
BMC Cancer|July 16, 2016
Method for semi-automated microscopy of filtration-enriched circulating tumor cellsEmma Pailler, Marianne Oulhen, Fanny Billiot, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 7, 2014
An open-label, multicenter, randomized, phase II study of pazopanib in combination with pemetrexed in first-line treatment of patients with advanced-stage non-small-cell lung cancerGiorgio V Scagliotti, Enriqueta Felip, Benjamin Besse, et al.
Lung Cancer (Amsterdam, Netherlands)|July 14, 2005
Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in non-small-cell lung cancerRafael Rosell, Yukito Ichinose, Miquel Taron, et al.
JCO Precision Oncology|December 21, 2023
Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary Thyroid CarcinomaJulien Hadoux, Abir Al Ghuzlan, Livia Lamartina, et al.
Future Oncology (London, England)|May 7, 2014
Dynamic contrast-enhanced MRI parameters as biomarkers for the effect of vatalanib in patients with non-small-cell lung cancerFelix Nensa, Jörg Stattaus, Bruno Morgan, et al.
Virchows Archiv : an International Journal of Pathology|February 25, 2021
Micronodular thymic carcinoma with lymphoid hyperplasia: relevance of immunohistochemistry with a small panel of antibodies for diagnosis-a RYTHMIC studyVincent Thomas de Montpreville, Audrey Mansuet-Lupo, Cécile Le Naoures, et al.
British Journal of Cancer|November 26, 2019
Association of the prognostic model iSEND with PD-1/L1 monotherapy outcome in non-small-cell lung cancerWungki Park, Laura Mezquita, Naoyuki Okabe, et al.
JCO Oncology Practice|February 23, 2021
Intercontinental Multidisciplinary Oncology Videoconferencing for Rare and Complex Cancer: An Alternative to Systematic TransferCharles Honoré, Olivier Mir, Arthur Geraud, et al.
European Journal of Cancer (Oxford, England : 1990)|February 25, 2018
Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group surveyAntonin Levy, Corinne Faivre-Finn, Baktiar Hasan, et al.
Lung Cancer (Amsterdam, Netherlands)|June 18, 2011
Phase II study of sunitinib as maintenance therapy in patients with locally advanced or metastatic non-small cell lung cancerRadj Gervais, John D Hainsworth, Normand Blais, et al.
Pageof 52

Showing results (291-300 of 512) with videos related to

Sort By:
Pageof 52
BMC Cancer|July 16, 2016
Method for semi-automated microscopy of filtration-enriched circulating tumor cellsEmma Pailler, Marianne Oulhen, Fanny Billiot, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 7, 2014
An open-label, multicenter, randomized, phase II study of pazopanib in combination with pemetrexed in first-line treatment of patients with advanced-stage non-small-cell lung cancerGiorgio V Scagliotti, Enriqueta Felip, Benjamin Besse, et al.
Lung Cancer (Amsterdam, Netherlands)|July 14, 2005
Mutations in the tyrosine kinase domain of the EGFR gene associated with gefitinib response in non-small-cell lung cancerRafael Rosell, Yukito Ichinose, Miquel Taron, et al.
JCO Precision Oncology|December 21, 2023
Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary Thyroid CarcinomaJulien Hadoux, Abir Al Ghuzlan, Livia Lamartina, et al.
Future Oncology (London, England)|May 7, 2014
Dynamic contrast-enhanced MRI parameters as biomarkers for the effect of vatalanib in patients with non-small-cell lung cancerFelix Nensa, Jörg Stattaus, Bruno Morgan, et al.
Virchows Archiv : an International Journal of Pathology|February 25, 2021
Micronodular thymic carcinoma with lymphoid hyperplasia: relevance of immunohistochemistry with a small panel of antibodies for diagnosis-a RYTHMIC studyVincent Thomas de Montpreville, Audrey Mansuet-Lupo, Cécile Le Naoures, et al.
British Journal of Cancer|November 26, 2019
Association of the prognostic model iSEND with PD-1/L1 monotherapy outcome in non-small-cell lung cancerWungki Park, Laura Mezquita, Naoyuki Okabe, et al.
JCO Oncology Practice|February 23, 2021
Intercontinental Multidisciplinary Oncology Videoconferencing for Rare and Complex Cancer: An Alternative to Systematic TransferCharles Honoré, Olivier Mir, Arthur Geraud, et al.
European Journal of Cancer (Oxford, England : 1990)|February 25, 2018
Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group surveyAntonin Levy, Corinne Faivre-Finn, Baktiar Hasan, et al.
Lung Cancer (Amsterdam, Netherlands)|June 18, 2011
Phase II study of sunitinib as maintenance therapy in patients with locally advanced or metastatic non-small cell lung cancerRadj Gervais, John D Hainsworth, Normand Blais, et al.
Pageof 52